Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by Keeleron Dec 13, 2023 9:51pm
435 Views
Post# 35783602

Ventura's and Tilray's gamble on Medmen

Ventura's and Tilray's gamble on Medmen I agree ventura - investing $1,200 to buy 60,000 Medmen shares is a bit comical.
What was the gamble - that it was going to go to .04 cents and you'd double your money?

Oh well, easy come - easy go, right.
BUT - here's a suggestion - given it appears Mdemen is likely to fold, you will indeed lose your $1,200 if you continue to hold. SO, you might want to consider selling at open tomorrow (unless Medmen's results beat you opening) - and buying Entourage.

Entourage sits at .01 cent - so you could buy 120,000 shares and if Ent hits .04 cents - well, my friend - pays for a nice little trip to Vegas plus some table money!
C'mon little 'v' - double down!!!!!!

Entourage, like Medmen, is also asscoiated with Tilray - Tilray extended the sales agreement Hexo had with Ent - and all 3 of Tilray, Hexo and Entourage products are maketed and distributed in Quebec by Rose Lifescience (a subsidary of Village Farms) 

As for Medmen getting a rec licence in New York - they don't have the licencing fee, but they wouldnt make it through the application process. A cannabis company doesn't get to 'jump in' the NY rec  sector - the State has a rigi review process. Cura and Cresco, two stocks I hold were among the first 6 who recently DID get their licences and Curaleaf began selling wholesale throughout New York State yesterday (population 20 million - one of the largest markets in the world).



Comment by Ventura2020on Dec 10, 2023 7:34pm
75 Views 
Post# 35777157

RE:Sure we spent the money years ago

"My $1200 US investment (60,000 shares) which I could sell tomorrow and Circlek loves to bring it up...comical. However, I wrote it off a long time ago as a gamble. The gamble is still in play and I will hold my cards. So, much better than Vegas...I'm still playing the slots and tables. 

New York settlement in and Medmen on 5th. Let's see if they jump into the Rec as well." 

<< Previous
Bullboard Posts
Next >>